{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T22:00:47Z","timestamp":1773525647348,"version":"3.50.1"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Intensive blood pressure (BP) control is effective in reducing major cardiovascular events. However, whether the reduction of systolic BP may lead to kidney injury remains controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To elucidate the association of intensive BP control with kidney and cardiovascular outcomes in individuals with hypertension without chronic kidney disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This study is a secondary analysis of the China Rural Hypertension Control Project (CRHCP), an open-label, blind-end-point cluster randomized trial conducted from May 8, 2018, to March 15, 2023, in 326 villages in China. Patients with a baseline estimated glomerular filtration rate (eGFR) of 60 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> or greater were randomized to an intervention or usual care group, stratified according to eGFR level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Exposures<\/jats:title><jats:p>A nonphysician community health care professional implemented a multifaceted intervention program after training to achieve a BP treatment goal of less than 130\/80 mm Hg.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Kidney outcome was defined as an eGFR decrease of 30% to a rate less than 60 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>. Composite cardiovascular outcomes included cardiovascular death, stroke, myocardial infarction, and heart failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 33\u202f332 patients with a baseline eGFR of 60 mL\/min\/1.73 m<jats:sup>2<\/jats:sup> or greater were included in this subgroup analysis (mean [SD] age, 62.8\u2009[9.1] years; 61.3% female). After 36 months of follow-up, in 7562 participants with eGFRs between 60 and 90 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>, 121 participants in the intervention group and 101 in the usual care group (risk ratio, 1.17; 95% CI, 0.82-1.62; <jats:italic>P<\/jats:italic>\u2009=\u2009.36) experienced kidney outcome, which was not statistically significant. As for cardiovascular outcomes, 210 participants (2.0% per year) in the intervention group and 346 participants (3.3% per year) in the usual care group had the composite cardiovascular disease outcome, and the disparity between the 2 groups was statistically significant (hazard ratio, 0.57; 95% CI, 0.47-0.68; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This secondary analysis of the CRHCP study suggests that intensive BP control was associated with reduced incidence of the composite cardiovascular disease outcome but not increased risk of kidney injury in patients without chronic kidney disease. These findings provide further evidence supporting the implementation of intensive BP control in patients without chronic kidney disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT03527719?term=NCT03527719\">NCT03527719<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.19604","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T15:30:36Z","timestamp":1752247836000},"page":"e2519604","source":"Crossref","is-referenced-by-count":4,"title":["Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes"],"prefix":"10.1001","volume":"8","author":[{"given":"Guozhe","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songyue","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangzhi","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danxi","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Evidence-Based Medicine, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitong","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanxiang","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuning","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"issue":"10304","key":"zoi250609r1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet"},{"issue":"19","key":"zoi250609r2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026432","article-title":"Differential patterns and outcomes of 20.6 million cardiovascular emergency department encounters for men and women in the United States.","volume":"11","author":"Raisi-Estabragh","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"zoi250609r3","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jacc.2023.11.003","article-title":"A heart-healthy and stroke-free world: using data to inform global action.","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"zoi250609r4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension.","volume":"18","author":"Zhou","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"zoi250609r5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1053\/j.ajkd.2020.12.013","article-title":"Association of blood pressure with the progression of CKD: findings from KNOW-CKD study.","volume":"78","author":"Lee","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"zoi250609r6","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2171887","article-title":"Advances in imaging techniques to assess kidney fibrosis.","volume":"45","author":"Jiang","year":"2023","journal-title":"Ren Fail"},{"issue":"20","key":"zoi250609r7","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1901281","article-title":"Final report of a trial of intensive versus standard blood-pressure control.","volume":"384","author":"Lewis","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"zoi250609r8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension.","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"10380","key":"zoi250609r9","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","article-title":"Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.","volume":"401","author":"He","year":"2023","journal-title":"Lancet"},{"issue":"22","key":"zoi250609r10","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control.","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"17","key":"zoi250609r11","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus.","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi250609r12","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"zoi250609r13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi250609r14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.7326\/M16-2966","article-title":"Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: a secondary analysis of a randomized trial.","volume":"167","author":"Beddhu","year":"2017","journal-title":"Ann Intern Med"},{"issue":"7","key":"zoi250609r15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S2213-8587(18)30099-8","article-title":"Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.","volume":"6","author":"Beddhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10339","key":"zoi250609r16","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0140-6736(22)00325-7","article-title":"A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial.","volume":"399","author":"Sun","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"zoi250609r17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/ajh\/hpab038","article-title":"Rationale and design of a cluster randomized trial of a village doctor-led intervention on hypertension control in China.","volume":"34","author":"Sun","year":"2021","journal-title":"Am J Hypertens"},{"issue":"16","key":"zoi250609r18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMra020676","article-title":"Renal dysfunction complicating the treatment of hypertension.","volume":"347","author":"Palmer","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi250609r19","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD.","volume":"28","author":"Cheung","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"zoi250609r20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1911965","article-title":"A community-based intervention for managing hypertension in rural South Asia.","volume":"382","author":"Jafar","year":"2020","journal-title":"N Engl J Med"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2836388\/sun_2025_oi_250609_1751902419.54188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T15:30:37Z","timestamp":1752247837000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2836388"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.19604","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}